- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07631975
ROLE OF DUAL-TASK COST IN PREDICTING FALL RISK AMONG OLDER ADULTS RECEIVING INSTITUTIONAL CARE
ROLE OF DUAL-TASK COST IN PREDICTING FALL RISK IN OLDER ADULTS RECEIVING INSTITUTIONAL CARE: A CROSS-SECTIONAL CLASSIFICATION MODEL
Panoramica dello studio
Stato
Descrizione dettagliata
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: Mine PEKESEN KURTÇA, ASISTANT PROFESSOR, PhD
- Numero di telefono: +903623121919
- Email: mine.pekesenkurtca@omu.edu.tr
Luoghi di studio
-
-
-
Samsun, Turchia (Türkiye), 55270
- ONDOKUZ MAYIS UNIVERSITY, Samsun, Atakum 55270
-
Contatto:
- MİNE PEKESEN P KURTÇA, PhD
- Numero di telefono: +903623121919
- Email: mine.pekesenkurtca@omu.edu.tr
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto più anziano
Accetta volontari sani
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Being 65 years of age or older
- Residing in a nursing home or care institution for at least 1 month
- Ability to walk a distance of at least 10 meters
- Ability to ambulate independently with an assistive device (e.g., cane, walker), if needed
- Having a Montreal Cognitive Assessment (MoCA) score of 18 or above
- Ability to understand and execute single- and two-step verbal commands
- Voluntary agreement to participate in the study and providing informed consent
Exclusion Criteria:
- History of stroke or major orthopedic surgery within the past 6 monthsPresence of Parkinson's disease Stage ≥3 (Hoehn & Yahr) or any other neurological condition significantly affecting gait
- Having a MoCA score below 18
- History of fracture within the past 3 months
- Presence of severe pain affecting gait during test administration (Visual Analog Scale [VAS] ≥ 7)
- Uncontrolled hypertension (≥ 180/100 mmHg) or unstable cardiovascular status
- Active vestibular disease or a history of syncope within the past 3 months
- Visual or hearing impairment severe enough to impede test execution
- Inability to walk/ambulate without the physical assistance of another person
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Clinical Information Form
Lasso di tempo: Single assessment (baseline)
|
The following participant information will be recorded using a clinical information form developed by the researcher: Age (years) Sex (male/female) Educational status(illitirate/primare education/secondary education/high school or higher) Length of institutional stay( months and years) Height(cm) Weight(kg) Body mass index BMI (kg/m²) Number of chronic diseases and comorbidities Number of daily medications Use of assistive devices |
Single assessment (baseline)
|
|
Fall Assesment
Lasso di tempo: Single assessment (baseline)
|
Fall history (Tripping, Slipping, Loss of Balance, Transposition) Fall History Questionnaire A fall will be defined as an event which results in an individual coming to rest inadvertently on the ground, floor, or a lower level. In this context, the following information will be recorded: Presence of a fall within the last 12 months (yes/no) Total number of falls within the last 12 months Presence of a fall within the last month (yes/no) Primary cause of the last fall Location of the last fall Injury status resulting from the last fall |
Single assessment (baseline)
|
|
Montreal Cognitive Assessment (MoCA)
Lasso di tempo: Single assessment (baseline)
|
This assessment will be utilized to determine whether participants possess the cognitive competence to understand and execute the study protocol.
Individuals with a MoCA score below 18 will be excluded from the study.
|
Single assessment (baseline)
|
|
Timed Up and Go Test (TUG)
Lasso di tempo: Single assessment (baseline)
|
This test will be utilized to assess the functional mobility of the participants.
The participant will be instructed to rise from a standard-height chair, walk a distance of 3 meters, turn around, return to the chair, and sit back down.
The duration of the test will be recorded in seconds.
|
Single assessment (baseline)
|
|
Dual-task Timed Up and Go Test (TUG-DT)
Lasso di tempo: Single assessment (baseline)
|
This test will be administered to evaluate the dual-task performance of the participants. Participants will be instructed to simultaneously perform a cognitive task during the TUG test. Cognitive Task Animal naming will be utilized as the cognitive task under the dual-task condition. The participant will be asked to name as many animals as possible while walking. All participants will be assigned the same task, and standard verbal instructions will be utilized. |
Single assessment (baseline)
|
|
Dual-Task Cost (DTC)
Lasso di tempo: Single assessment (baseline)
|
The dual-task cost will be calculated using the single-task TUG and dual-task TUG durations according to the following formula: DTC (%)"=(TUG_DT-TUG)/TUG×100 An increase in the DTC percentage will indicate greater performance degradation under the dual-task condition.
|
Single assessment (baseline)
|
|
Tinetti Performance-Oriented Mobility Assessment (POMA)
Lasso di tempo: Single assessment (baseline)
|
This assessment will be utilized to evaluate the balance and gait performance of the participants. The total Tinetti score will be used to determine the risk of falls. Operational Definition of Fall Risk Fall risk will be operationalized in two ways in the study: As a continuous variable: Total Tinetti score As a binary classification variable: Risk group based on the Tinetti score Classification based on the Tinetti score will be structured as follows: Low fall risk: 25-28 points Increased fall risk: 24 points and below This binary classification will be utilized for the classification model and ROC analysis. |
Single assessment (baseline)
|
|
Falls Efficacy Scale-International (FES-I)
Lasso di tempo: Single assessment (baseline)
|
This scale will be utilized to assess the participants' level of fear of falling as a descriptive and secondary variable.
The FES-I score will not serve as a primary variable in the main model; however, it will be reported in descriptive analyses and secondary analyses as required.
|
Single assessment (baseline)
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 2026/276
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .